CD30 Ligand/CD30 Interaction Is Involved in Pathogenesis of Inflammatory Bowel Disease

被引：0
|
作者：
Shinichi Somada
Hiromi Muta
Kazuhiko Nakamura
Xun Sun
Kuniomi Honda
Eikichi Ihara
Hirotada Akiho
Ryoichi Takayanagi
Yasunobu Yoshikai
Eckhard R. Podack
Kenzaburo Tani
机构：
[1] Kyushu University Hospital,Department of Advanced Molecular and Cell Therapy
[2] Kyushu University,Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences
[3] Kyushu University,Division of Host Defense, Research Center For Prevention of Infectious Diseases, Medical Institute of Bioregulation
[4] Kyushu University,Research Center for Advanced Immunology
[5] China Medical University,Institute of Immunology
[6] University of Miami,Department of Microbiology and Immunology, Miller School of Medicine
来源：
Digestive Diseases and Sciences | 2012年 / 57卷
关键词：
CD30; CD30 ligand; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2031 / 2037
页数：6
相关论文
共 50 条
  • [21] Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population
    S Ahmed
    K Ihara
    W M Bassuny
    R Kuromaru
    H Kohno
    K Miyako
    N Matsuura
    I Iwata
    S Nagafuchi
    T Hara
    Genes & Immunity, 2002, 3 : 96 - 101
  • [22] EXPRESSION AND MODULATION OF CD30 LIGAND AND CD30 IN 102 HUMAN LEUKEMIA-LYMPHOMA CELL-LINES
    GRUSS, HJ
    DASILVA, N
    HU, ZB
    MA, W
    UPHOFF, CC
    GOODWIN, RG
    DREXLER, HG
    BLOOD, 1993, 82 (10) : A482 - A482
  • [23] Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors
    Pera, MF
    Bennett, W
    Cerretti, DP
    LABORATORY INVESTIGATION, 1997, 76 (04) : 497 - 504
  • [24] Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation
    Frisaldi, E
    Conca, R
    Magistroni, P
    Fasano, ME
    Mazzola, G
    Patanè, F
    Zingarelli, E
    Dall'Omo, AM
    Brusco, A
    Amoroso, A
    TRANSPLANTATION, 2006, 81 (08) : 1153 - 1156
  • [25] Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation
    Frisaldi, E.
    Conca, R.
    Magistroni, P.
    Fasano, M. E.
    Mazzola, G.
    Patane, F.
    Amoroso, A.
    TISSUE ANTIGENS, 2006, 67 (06): : 505 - 505
  • [26] CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues
    Gruss, HJ
    Pinto, A
    Gloghini, A
    Wehnes, E
    Wright, B
    Boiani, N
    Aldinucci, D
    Gattei, V
    Zagonel, V
    Smith, CA
    Kadin, ME
    vonSchilling, C
    Goodwin, RG
    Herrmann, F
    Carbone, A
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (02): : 469 - 481
  • [27] CD30 expression in seminoma
    Hittmair, A
    Rogatsch, H
    Hobisch, A
    Mikuz, G
    Feichtinger, H
    HUMAN PATHOLOGY, 1996, 27 (11) : 1166 - 1171
  • [28] CD30 Diagnostics and Testing
    Young, Ken H.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (04) : 9 - 15
  • [29] Characterisation of the human CD30 ligand gene structure
    Croager, EJ
    Abraham, LJ
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1997, 1353 (03): : 231 - 235
  • [30] Relapsed or refractory CD30
    Rossignol, Julien
    Morschhauser, Franck
    HEMATOLOGIE, 2011, 17 (02): : 113 - 115
12345